Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

By implementing appropriate security measures, threat assessment protocols, and compliance-driven policies, healthcare ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

Rohit Loomba, M.D., will hold the new endowed chair that was established in honor of the late biotech leader John C. Martin to further liver disease research ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for ...

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of ...

CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...

A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS ...

Continued execution on collaborations and exploratory investigator-initiated studies with institutional partners ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Hematological malignancies represent defying clinical conditions affecting either the lymphoid or the myeloid lineages. Targeted therapy research is developing rapidly from bench to bedside based on ...